(Q72892939)
Statements
Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49 (English)
L Kostakoglu
C R Divgi
S Hilton
C Cordon-Cardo
A M Scott
H Kalaigian
R D Finn
J Schlom